Nomura Holdings’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-68,300
| Closed | -$227K | – | 1034 |
|
|
2023
Q4 | $227K | Buy |
68,300
+47,290
| +225% | +$157K | ﹤0.01% | 942 |
|
|
2023
Q3 | $78.6K | Sell |
21,010
-45,407
| -68% | -$170K | ﹤0.01% | 714 |
|
|
2023
Q2 | $284K | Sell |
66,417
-1,883
| -3% | -$8.04K | ﹤0.01% | 593 |
|
|
2023
Q1 | $467K | Buy |
68,300
+22,626
| +50% | +$155K | ﹤0.01% | 635 |
|
|
2022
Q4 | $360K | Hold |
45,674
| – | – | ﹤0.01% | 630 |
|
|
2022
Q3 | $441K | Buy |
45,674
+21,524
| +89% | +$208K | ﹤0.01% | 712 |
|
|
2022
Q2 | $189K | Sell |
24,150
-34,150
| -59% | -$267K | ﹤0.01% | 899 |
|
|
2022
Q1 | $749K | Buy |
58,300
+28,462
| +95% | +$366K | ﹤0.01% | 791 |
|
|
2021
Q4 | $476K | Sell |
29,838
-5,961
| -17% | -$95.1K | ﹤0.01% | 1074 |
|
|
2021
Q3 | $591K | Buy |
35,799
+11,988
| +50% | +$198K | ﹤0.01% | 949 |
|
|
2021
Q2 | $330K | Sell |
23,811
-9,190
| -28% | -$127K | ﹤0.01% | 1183 |
|
|
2021
Q1 | $482K | Buy |
+33,001
| New | +$482K | ﹤0.01% | 1010 |
|